Bloom Review 2026 (Historical): The Consumer CBT App That Shut Down in February 2025

Quick Verdict (Historical)

Bloom was a thoughtfully designed video-led CBT app that translated key therapy techniques into short, structured exercises. It offered a more cinematic, course-like experience than chat-based competitors. However, it never matched the clinical research depth of Wysa or Woebot, and as Spring Health's strategic focus consolidated around enterprise mental health benefits, the consumer Bloom product was sunset in February 2025.

What Bloom Did

Bloom delivered CBT-derived self-guided programs through short video sessions paired with reflective exercises. Users worked through programs on anxiety, stress, sleep, self-esteem, relationships, and burnout. The visual production quality was higher than the typical text-based therapy chatbot, which appealed to users who preferred a course-style experience over chat.

Why Bloom Was Discontinued (February 2025)

Spring Health's core business is enterprise mental health benefits — partnering with employers and health plans to provide therapy, coaching, and care navigation to covered members. The Bloom consumer app was a separate product line that never reached the scale or contribution margin of the enterprise business. In February 2025, Spring Health announced the discontinuation of the standalone Bloom app to concentrate resources on its core enterprise platform. The decision is consistent with a broader pattern in 2024-2025 where multiple consumer mental health products were sunset by companies whose primary business is B2B.

What Former Bloom Users Should Use Instead

• Wysa — strongest clinically validated consumer AI therapy chatbot (30+ publications). Wysa review
• MindDoc — for users who valued structured assessment and mood tracking. MindDoc review
• Spring Health (via your employer) — if your employer offers Spring Health as a benefit, you may have access to therapists, coaches, and care navigation through that program directly
• Talkiatry — for US adults needing professional psychiatric care covered by insurance. Talkiatry review

Lessons from the Bloom Shutdown

Bloom's story, like Woebot's, illustrates how fragile consumer mental health subscription businesses can be — even when backed by well-funded parent companies. Users selecting an AI mental health app in 2026 should weight not only product quality and clinical evidence but also the strategic alignment of the product with its company's primary business. Tools whose company's core revenue depends on the product itself are generally more durable than orphaned consumer products inside enterprise-focused companies.

Why Spring Health Discontinued Bloom

Spring Health is, at its core, an enterprise mental health benefits company. Its go-to-market motion sells to HR leaders, benefits consultants, and health plan administrators — not to individual consumers. Revenue comes from per-member-per-month contracts with employers who offer Spring Health as part of their EAP or behavioral health benefit. The consumer Bloom app sat awkwardly outside that motion. It required a separate marketing funnel, separate subscription billing infrastructure, separate customer support, and separate product roadmap bandwidth — all to serve a customer who, by definition, was not paying Spring Health's enterprise contract rates.

Spring Health acquired Bloom (originally launched as a standalone startup) as part of its broader expansion into self-guided digital interventions. The thesis at the time was that a self-guided product could serve covered members of enterprise clients as a first rung on the stepped-care ladder, while also generating independent consumer revenue. In practice, the consumer business never scaled to justify its ongoing investment, and covered members of Spring Health's enterprise clients already had access to live therapists, coaches, and care navigation through the core product — making a separate self-guided app largely redundant.

The February 2025 discontinuation fit a much broader industry pattern. Throughout 2024 and 2025, venture capital for direct-to-consumer mental health apps tightened dramatically. Investors who had previously funded consumer wellness plays pivoted toward B2B and enterprise deals where contracted revenue and lower churn offered clearer paths to profitability. Spring Health's decision to sunset Bloom was less a product failure than a strategic alignment: its cash and talent were better spent scaling the enterprise platform that pays the bills.

What Made Bloom Distinctive

Among the crowded field of AI and digital mental health tools, Bloom occupied a specific niche: CBT-grounded, video-first, therapist-narrated content structured as guided journeys rather than reactive conversations. Each "class" featured a licensed therapist on camera walking users through a particular CBT concept — cognitive distortions, behavioral activation, thought records — paired with reflective exercises and journaling prompts.

Users consistently reported that the video format felt warmer and more human than text-based chatbots. Seeing an actual clinician explain a CBT technique produced parasocial engagement that Wysa or Woebot's scripted chat interactions could not replicate. The "guided journey" structure — a multi-week sequence of related sessions rather than an open-ended chat — gave users a clear sense of progress and a finite commitment.

Bloom's clinical advisory board included practicing psychologists who helped shape the curriculum, and the production values were notably higher than most of the category. For users who found chatbots impersonal and self-help books too abstract, Bloom filled a real gap.

What Former Bloom Users Should Use Instead

No single product in 2026 replicates Bloom's full experience. Former users should pick a replacement based on which dimension of Bloom mattered most to them.

• For self-guided CBT content \u2192 Wysa or MindDoc. Wysa is the closest evidence-based equivalent for structured CBT skills, though it delivers them through chat rather than video. With 30+ peer-reviewed papers, it is the most clinically validated consumer AI therapy app available. MindDoc takes a more assessment-driven approach, grounding self-help in PHQ-9 and GAD-7 measurement. Neither offers Bloom's video production, but both are available and actively maintained. Wysa review | MindDoc review
• For mood tracking \u2192 MindDoc or Youper. Bloom's daily mood check-ins were a popular feature. MindDoc is the strongest mood-tracking-first option, with validated clinical instruments built in. Youper combines mood tracking with an AI conversation layer and has Stanford-affiliated research behind its symptom assessment engine. Youper review
• For therapist video sessions \u2192 BetterHelp or Talkiatry. If what you really valued about Bloom was seeing a therapist on camera, the honest truth is that the replacement is live therapy. BetterHelp offers text and video sessions with licensed therapists on a subscription basis. Talkiatry is a better fit for US adults who need psychiatric care and have insurance coverage. Neither is self-guided, and both cost more than Bloom did, but both deliver a real human clinician. Talkiatry review

An honest comparison: nothing currently on the market delivers Bloom's particular combination of high-production video, therapist narration, structured CBT journeys, and consumer pricing. The closest functional replacement for the clinical content is Wysa. The closest replacement for the "seeing a real clinician" experience is live therapy. Choose based on which Bloom attribute mattered most.

Lessons for the AI Mental Health Market

Bloom's shutdown is worth studying because it was not a failure of product quality. Bloom was a well-designed, well-produced, clinically-grounded app that users genuinely liked. It still did not survive. The lessons for the industry in 2026:

• Self-guided digital interventions struggle to sustain engagement. Across the category, retention curves for self-guided mental health apps drop sharply after the first few weeks. Users who start strong often disengage before the intervention can produce measurable clinical benefit.
• VC funding for D2C wellness has contracted sharply. The 2021\u20132022 consumer health boom is over. Investors now want contracted B2B revenue, not churn-prone subscription funnels.
• B2B enterprise mental health (EAP, employer benefits) is the sustainable model. Products sold into employer benefits packages benefit from low churn, predictable revenue, and integration with existing HR workflows. That is where the money and attention are going.
• Even VC-backed consumer mental health fails without insurance coverage. Direct-to-consumer mental health products without a path to reimbursement or enterprise distribution face a structural ceiling. Bloom had a well-capitalized parent and still got sunset.

Frequently Asked Questions

Can I still access my Bloom data?

Spring Health discontinued the consumer Bloom app in February 2025. Former users who want a copy of their session history, mood logs, or journal entries should contact Spring Health support directly to request a data export under applicable privacy regulations (GDPR in the EU, CCPA in California, and similar state-level rules in the US). Once the discontinuation transition period ends, data retention policies are at the discretion of Spring Health and may be limited to regulatory minimums.

Is the Bloom approach available anywhere else?

There is no direct replica of Bloom's therapist-narrated CBT video library on the consumer market in 2026. The closest alternatives are Wysa for clinically validated CBT (chat-based rather than video), MindDoc for structured mood tracking and PHQ-9/GAD-7 grounded assessment, and BetterHelp or Talkiatry for live video therapy with a real clinician. None fully reproduce Bloom's format, but together they cover the functional needs former Bloom users typically had.

Why are so many AI mental health consumer apps shutting down?

Consumer mental health apps face high subscription churn, rising customer acquisition costs, and increasing regulatory scrutiny around AI health claims. Meanwhile, B2B channels (employer benefits, EAPs, health plans) offer stable contracted revenue. In 2024\u20132025, VC funding for direct-to-consumer wellness apps tightened sharply, pushing even well-funded products like Bloom and Woebot's consumer app to shut down in favor of enterprise strategies. The pattern is likely to continue through 2026.

Bottom Line

Bloom was a beautifully produced consumer CBT app that did not survive its parent company's strategic refocus on enterprise mental health benefits. For former users seeking a replacement, Wysa offers the most evidence-backed alternative available today, MindDoc the strongest mood-tracking substitute, and live therapy through BetterHelp or Talkiatry the closest match for the "real clinician on video" experience Bloom delivered at consumer pricing.